Germany· DE-A57-b3f4a37a6e5de494
Destillat Aus Pfefferminzöl, Cajeputöl, Eukalyptusöl Olbas
A medicinal product containing peppermint oil, cajuput oil, eucalyptus oil, registered in Germany by Deutsche Olbas Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Peppermint Oil, Cajuput Oil, Eucalyptus Oil
- Manufacturer
- Deutsche Olbas Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Peppermint oil, cajuput oil, eucalyptus oil in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/20092ad9-e781-40bb-82ed-40e979b4d91e GET /v1/drugs/20092ad9-e781-40bb-82ed-40e979b4d91e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Cutaneous Use, Inhalation Use, Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Peppermint Oil, Cajuput Oil, Eucalyptus Oil",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about peppermint oil, cajuput oil, eucalyptus oil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.